Amantadine

Common brands: Gocovri, Vitamin D, Neurontin, Rytary, Gralise

Top reporter: Adamas Pharma, Llc

Influenza A M2 Protein Inhibitor [EPC]Aromatic Amino Acid [EPC]Benzodiazepine [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Provitamin D2 Compound [EPC]
15,043
Total Reports
6,172
Serious Reports
1,594
Death Reports
30
Reported Reactions
Death Report Ratio: High (10.60%)

Patient Demographics

Male
6,105
Female
7,738

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Amantadine.

# Reaction Reports % of Total
1 FALL 1,729
8.4%
2 HALLUCINATION 1,270
6.1%
3 DRUG INEFFECTIVE 1,239
6.0%
4 FATIGUE 1,082
5.2%
5 DYSKINESIA 1,062
5.1%
6 DIZZINESS 928
4.5%
7 GAIT DISTURBANCE 884
4.3%
8 DEATH 848
4.1%
9 TREMOR 790
3.8%
10 NAUSEA 665
3.2%
11 PARKINSON^S DISEASE 658
3.2%
12 ASTHENIA 634
3.1%
13 BALANCE DISORDER 612
3.0%
14 CONDITION AGGRAVATED 608
2.9%
15 URINARY TRACT INFECTION 605
2.9%
16 CONFUSIONAL STATE 601
2.9%
17 SOMNOLENCE 595
2.9%
18 INSOMNIA 561
2.7%
19 CONSTIPATION 537
2.6%
20 OFF LABEL USE 515
2.5%
21 HEADACHE 479
2.3%
22 PRODUCT DOSE OMISSION ISSUE 443
2.1%
23 ANXIETY 438
2.1%
24 HALLUCINATION, VISUAL 438
2.1%
25 PAIN 436
2.1%
26 DEPRESSION 433
2.1%
27 MALAISE 432
2.1%
28 WEIGHT DECREASED 401
1.9%
29 MULTIPLE SCLEROSIS RELAPSE 382
1.8%
30 FEELING ABNORMAL 377
1.8%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.